Watson Laboratories seeks FDA approval to market Colesevelam HCI tablets - 研发专利新闻

添加时间:2011-04-23 原文发表:2011-04-23 人气:4

Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market...

查看所有的文章内容需要 VIP会员权限查看

点这里复制本页地址发送给您QQ/MSN上的好友

• Salix Pharmaceuticals receives three U.S

• Acorda receives patent for AMPYRA tablet

• U.S. District Court grants preliminary i

• QRxPharma receives new U.S. Patent for M

• EPO grants patent to OncoGenex OGX-427 f

• Echo awarded method patent for Symphony

• USPTO issues new patent to Onset Medical

• Watson confirms patent challenge by Alco

• EPO Board of Appeal rejects B.Braun pate

• USPTO issues notice of allowance to Mirn

• WSU researcher develops potential vaccin

• USPTO issues patent to Oragenics ProBior

• POZEN, AstraZeneca file lawsuit against

• Pro-Pharmaceuticals receives method pate

• NovaSterilis novel vaccine patent

• USPTO grants Cortex patent for CX1739 AM

• EPO grants patent to Microbix' VIRUSMAX

• MSF letter criticizes Johnson & Johnson

网站首页

行业信息

市场快讯

SFDA新闻精选

调研报告

研发动态

研发专利新闻

新闻公告

您的位置：网站名称 → 研发专利新闻 → 正文